¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"È£"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
mouth to mouth breathing
ÀÔ´ëÀÔÀΰøÈ£Èí(¹ý)
mouth to nose breathing
ÀÔ´ëÄÚÀΰøÈ£Èí(¹ý)
mouth-to-mouth respiration
ÀÔ´ëÀÔÈ£Èí
MR signal
ÀÚ±â°ø¸í½ÅÈ£
mucosal protective drug
Á¡¸·º¸È£Á¦
mutual exclusion
»óÈ£¹èÁ¦
mutual solubility
»óÈ£¿ëÇØµµ
malodorous breath
¾ÇÃëÈ£Èí
Mycoplasma hominis
¹ÌÄÚÇö󽺸¶È£¹Ì´Ï½º
mysophilia
ºÒ°á±âÈ£Áõ
maximal breathing capacity
ÃÖ´ëÈ£Èí¿ë·®
maximal expiratory flow
Ãִ볯¼ûÀ¯·®, ÃÖ´ëÈ£±â·®
maximal expiratory level
Ãִ볯¼û¼öÁØ, ÃÖ´ëÈ£±â°ª
maximal midexpiratory flow rate
ÃÖ°íÁß°£³¯¼ûÀ¯¼Ó, ÃÖ°íÁß°£È£±âÀ¯¼Ó
maximum breathing capacity
ÃÖ´ëÈ£Èí¿ë·®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
protective glasses
º¸È£¾È°æ
sex hormone-binding globulin
¼ºÈ£¸£¸ó°áÇÕ±Û·Îºí¸°
hormocardiol
½ÉÀåÈ£¸£¸ó
horopter
´ÜÀϽñ˵µ, È£·ÓÅÍ
hospice
ÀÓÁ¾°£È£, È£½ºÇǽº
hypereosinophilia
°ú´ÙÈ£»ê±¸Áõ°¡Áõ
hyperestrinism
¿©¼ºÈ£¸£¸ó°ú´ÙÁõ
hyperpnea
°ú´ÙÈ£Èí, È£ÈíÇ×Áø
hyperventilation
°ú´ÙÈ£Èí
hypoeosinophilia
(¢¡eosinopenia) È£»ê±¸°¨¼ÒÁõ
health protection
°Ç°º¸È£
high signal
°í½ÅÈ£
high signal intensity
°í½ÅÈ£°µµ
high velocity signal loss
°í¼Óµµ½ÅÈ£¼Ò½Ç
host preference
¼÷ÁÖ¼±È£
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
hypereosinophilic cardiomyopathy
°úÈ£»ê±¸¼º ½É±Ùº´Áõ
hypereosinophilic syndrome
°úÈ£»ê±¸Áõ°¡ÁõÈıº
hypereosinophilic syndrome
°úÈ£»ê±¸ ÁõÈıº, °íÈ£»ê±¸ÁõÈıº
hypereosinophilic syndrome
°úÈ£»ê±¸¼º ÁõÈıº
hypergonadotropic hypogonadism
°í¼º¼±ÀÚ±ØÈ£¸£¸ó¼º ¼º¼±ºÎÀüÁõ
hyperhormonal =hyperhormonic
°úÈ£¸£¸ó¼ºÀÇ.
hyperpnea
°úÈ£Èí(Φû¼ýå), È£ÈíÇ×Áø(û¼ýåùñòä).
hyperprolactinemia
°íȲüÀÚ±ØÈ£¸£¸ó<°íÇÁ·Î¶ôƾ>Ç÷Áõ
hyperprolactinemia
°úÇ×üÀÚ±ØÈ£¸£¸óÇ÷Áõ
hyperprolactinemia
À¯ÁóºÐºñÈ£¸£¸ó°ú(´Ù)Ç÷Áõ
hypersegmented neutrophils
°úºÐ¿±È£Áß±¸(¡û¿ñéϹ).
hypersegmented neutrophils
°úºÐ¿±È£Áß±¸(?̴̡˴).
hyperventilation
°úÈ£Èí
hyperventilation
°ú´ÙÈ£Èí
hyperventilation
°úȯ±â(ΦüµÑ¨), ȯ±âÇ×Áø, È£ÈíÇ×Áø, °úÈ£Èí.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
neutrophilic leukemia
È£Áß±¸¼º ¹éÇ÷º´
neutrophilic leukemoid reaction
È£Áß±¸¼º ¹éÇ÷º´¾ç ¹ÝÀÀ
neutrophilic eccrine hidradenitis
È£Áß±¸¼º ¿¡Å©¸° ÇѼ±¿°
neutrophil alkaline phosphatase
È£Áß±¸¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦
neutrophilia
È£Áß±¸Áõ°¡(Áõ)
neutrophilia
È£Áß±¸Áõ°¡(Áõ)(¡ñòÊ¥ñø)
neutrophilia
È£Áß±¸Áõ´ÙÁõ
neutrophilic leukocytosis
È£Áß±¸Áõ´ÙÁõ(¡ñøÒýñø), È£Áß±¸¼º ¹éÇ÷±¸Áõ´ÙÁõ(¡àõ ÛÜúìϹñøÒýñø)
neutrophilic leukocytosis
È£Áß±¸Áõ´ÙÁõ, È£Áß±¸¼º ¹éÇ÷±¸Áõ´ÙÁõ.
neutrophil specific antigen
È£Áß±¸Æ¯ÀÌÇ׿ø.
neutrophil granule
È£Áß¼º °ú¸³(~?Ëö), Áß¼ºÄ£È(¼º) °ú¸³.
neutrophilic leukocyte
È£Áß¼º ¹éÇ÷±¸(~ËÑÌ´Ë´).
neutrophil leucocyte
È£Áß¼º ¹éÇ÷±¸(¡ÛÜúìϹ)
neutrophilic leukocyte
È£Áß¼º ¹éÇ÷±¸(¡ÛÜúìϹ)
neutrophil leucocyte
È£Áß¼º ¹éÇ÷±¸(Ì´Ì¡ËÛËÑÌ´Ë´).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
co-dominance
»óÈ£º¹¼º
code
¾ÏÈ£, ºÎÈ£, ±Ô¾à
code
ºÎÈ£, ÄÚµå
coding unit
ºÎȣ󸮴ÜÀ§.
codominance
»óÈ£º¹¼º.
codominance
»óÈ£º¹¼º(ßÓû»ÜÜàõ)
codon
ÄÚµ·, À¯ÀüºÎÈ£.
codon
ÄÚµ·, À¯ÀüÀÚºÎÈ£
cohort effect
ÄÚȣƮ È¿°ú(~üùÍý)
color naming
»öÀ̸§´ë±â, »ö¸íȣĪ
committee on nursing procedures
°£È£¹æ¹ýÀ§¿øÈ¸(¡Û°ÛöêÍê¬üå).
community nurse
Áö¿ª»çȸ°£È£»ç(ÊÙ˧̴Ë×).
compatible
ȣȯ(¼º)ÀÇ, ÇÕ´çÇÑ
complaint
È£¼Ò ¡ìÁõ»ó(ñøßÒ)ÀÇ¡í, º´¼Ò, ¡ÈÄ.
complaints of patient
ȯÀÚÀÇ È£¼Ò(ü´íº¡û¼áÍ).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½